ABPI chief backs call to collaborate with EU on life sciences
5 Jul 2017
The Association of the British Pharmaceutical Industry (ABPI) has backed a call by Jeremy Hunt and Greg Clark to collaborate with the EU on life sciences after Brexit.
The ministers outlined plans for the regulation of medicines as the UK leaves the EU in a letter published in the Financial Times on Monday (3 July).
According to the FT, the letter said “the UK would like to find a way to continue to collaborate with the EU, in the interests of public health and safety”.
In response, ABPI chief executive Mike Thompson said: “This is a great first step and we look forward to seeing more detail in the coming weeks and months.”
He added that the letter also signalled “a readiness to take a pragmatic approach to Brexit negotiations that puts people’s health first”.
Thompson argued that if patients in Europe were to continue to get safe and effective medicines in a timely fashion, the focus must be on agreeing regulatory partnership between the UK and the EU.
He said: "The timeframes we need to meet to ensure no disruption or delay mean that confirmation of a reciprocal approach from the EU would provide welcome certainty to more than 500 million patients."
There are no comments on this article, leave a comment below to have your say